Search

Your search keyword '"Annette Schmitt-Graeff"' showing total 199 results

Search Constraints

Start Over You searched for: Author "Annette Schmitt-Graeff" Remove constraint Author: "Annette Schmitt-Graeff" Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals
199 results on '"Annette Schmitt-Graeff"'

Search Results

1. Case report: Lichenoid esophagitis revealing an HIV infection

2. ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease

3. Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation

4. Therapeutic targeting of endoplasmic reticulum stress in acute graft-versus-host disease

5. Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect

6. Cyclic GMP in Liver Cirrhosis—Role in Pathophysiology of Portal Hypertension and Therapeutic Implications

7. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension

8. Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor β gene

9. Esophageal lichen planus: Current knowledge, challenges and future perspectives

10. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma

11. Data from Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice

12. Supplementary Figures 1-7 from Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice

13. Supplementary Data from miR-146a Controls Immune Response in the Melanoma Microenvironment

14. Data from miR-146a Controls Immune Response in the Melanoma Microenvironment

15. Human β-defensin 2 ameliorates acute GVHD by limiting ileal neutrophil infiltration and restraining T cell receptor signaling

16. RETRACTED: Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer

17. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

18. Therapeutic targeting of endoplasmic reticulum stress in acute graft-versus-host disease

19. Oncogenic KrasG12D Activation in the Nonhematopoietic Bone Marrow Microenvironment Causes Myelodysplastic Syndrome in Mice

20. Diagnostic and therapeutic challenge of unclassifiable enteropathies with increased intraepithelial CD103+ CD8+ T lymphocytes: a single center case series

21. Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study

22. Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect

23. Deep abscopal response to radiotherapy and anti-PD-1 in an oligometastatic melanoma patient with unfavorable pretreatment immune signature

24. Loss of the Fanconi anemia–associated protein NIPA causes bone marrow failure

25. Immunization against poly- N -acetylglucosamine reduces neutrophil activation and GVHD while sparing microbial diversity

26. Gastric cancer and paraneoplastic dermatomyositis as complications of an unrecognized juvenile polyposis syndrome

27. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression

28. miR-146a Controls Immune Response in the Melanoma Microenvironment

29. Retraction notice to 'Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer' [Canc. Lett. 520 (2021) 385–399]

30. Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer

31. T cell exhaustion dynamics are linked to clinical outcomes in Hepatocellular Carcinoma

32. Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension

33. Altered Spectrum of Lymphoid Neoplasms in a Single-Center Cohort of Common Variable Immunodeficiency with Immune Dysregulation

34. TIM‐3 deficiency presenting with two clonally unrelated episodes of mesenteric and subcutaneous panniculitis‐like T‐cell lymphoma and hemophagocytic lymphohistiocytosis

35. Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation

36. Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans

37. Oncogenic

38. Malignant Lymphomas

39. Acute Leukemia of Myeloid, Lymphoid, and Ambiguous Lineage and Related Malignancies

40. Increase of Plasma Cells, Reactive and Neoplastic

41. Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB, FGFR1, or with PCM1-JAK2

42. MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors

43. Glucagon like peptide-2 for Intestinal stem cell and Paneth cell repair during graft-versus-host disease in mice and humans

44. Mastocytosis

46. Myelodysplastic Syndromes (MDS)

47. Bone Changes Found in Bone Marrow Biopsies

48. Myeloproliferative Neoplasm (MPN)

49. Normal Bone Marrow

50. Non-neoplastic Conditions with Quantitative and Qualitative Changes in Hematopoiesis

Catalog

Books, media, physical & digital resources